AlphAIAlphAI — Financial news for AI agents
SEC EDGARJUL 271 min read$ANIX

KUMAR AMIT purchased $11K of ANIX

KUMAR AMIT (Chief Executive Officer) purchased 3,000 shares of Anixa Biosciences Inc (ANIX) at $3.73 on 2026-07-24.

Original reporting
SEC EDGAR · KUMAR AMIT
Published Jul 27, 2026, 1:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 27, 2026, 1:15 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$ANIX
Bullish
medium confidence
Mentioned
$ANIX
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ANIXBullishLow
01

Why it matters

The newest fact is the CEO’s open-market purchase details (3,000 shares at $3.73, $11,190 total) and the post-transaction holdings (643,812 shares).

02

Market read

Traders may view the insider buy as a small sentiment positive, but it is not a fundamental catalyst.

03

What to watch

The article notes no pre-arranged 10b5-1 plan, but it still does not provide intent, timing constraints, or whether the CEO has other concurrent transactions.

Relevance 4/10Novelty 3/10Timing: Form 4 filed 2026-07-27, covering a 2026-07-24 purchase.

Background

This is an SEC Form 4 insider transaction disclosure for Anixa Biosciences, reported by CEO Kumar Amit.

Company-level read

Ticker impact

$ANIXBullishMedium confidence
Context

CEO insider open-market purchase of 3,000 shares at $3.73 on 2026-07-24, disclosed via Form 4 filed 2026-07-27.

Expected impact

Likely limited near-term impact; may modestly support sentiment if traders track insider activity.

Evidence & confidence

Form 4 confirms the transaction details (shares, price, total value) and insider role, but it is not tied to new company fundamentals or guidance.

Market effects

Sector

No sector-level read-through; this is a single-company insider transaction.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Insider buys can be routine (tax planning, diversification, or pre-planned activity) and may not reflect a change in business outlook.

Key entities

  • issuer
    Anixa Biosciences Inc

    Subject of the Form 4 insider transaction disclosure.

  • insider
    Kumar Amit

    CEO and officer/director who purchased shares.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

ANIX insider trading history →

Related articles

SEP 11
$ANIXMedAI 8/10

RedChip Companies, Inc.: Anixa Biosciences and Nexalin Technology Interviews to Air Nationally on the RedChip Small Stocks, Big Money Show on CNBC and Bloomberg TV

RedChip Companies will air interviews with Anixa Biosciences (NASDAQ:ANIX) and Nexalin Technology (NASDAQ:NXL) on Bloomberg TV and CNBC. Anixa is developing a breast cancer vaccine, while Nexalin focuses on neurostimulation for mental health. Both companies are preparing for key trials and commercialization efforts.

finanznachrichten.de2 min
SEP 17
$INGMHighAI 8/10

PLATINUM EQUITY, LLC (Gores Tom) sold $53.5M of INGM (indirect holdings)

PLATINUM EQUITY, LLC sold 1,968,750 indirectly-held shares of Ingram Micro Holding Corp (INGM) at $27.19 ($53.53M total) on 2026-09-15. Filed jointly with Platinum Equity Investment Holdings, LLC (10% owner), Platinum Equity Investment Holdings IC (Cayman), LLC (10% owner), Platinum Equity InvestCo, L.P. (10% owner), Platinum Equity Investment Holdings V, LLC (10% owner), Platinum Equity Partners V, LLC (10% owner), Platinum Equity Partners V, L.P. (10% owner), Imola JV Holdings, L.P. (10% owner), Ingram Holdco, LLC (10% owner) and Gores Tom (10% owner).

SEC EDGAR1 min
SEP 17
$XBPLow

Avenue RP Opportunities Fund, L.P. (LASRY MARC) purchased $1.5M of XBP (indirect holdings)

Avenue RP Opportunities Fund, L.P. purchased 527,606 indirectly-held shares of XBP Global Holdings, Inc. (XBP) at $2.83 ($1.49M total) across 2 trades on 2026-09-15. Filed jointly with Avenue Global Dislocation Opportunities Fund, L.P. (10% owner), Avenue Europe International Management, L.P. (10% owner), Avenue Capital Management II, L.P. (10% owner), Avenue RP Opportunities Fund GenPar, LLC (10% owner), Avenue Global Dislocation Opportunities GenPar, LLC (10% owner), GL RP Partners, LLC (10% owner), GL Global Dislocation Opportunities Partners, LLC (10% owner) and LASRY MARC (10% owner).

SEC EDGAR1 min